Short interest in Galectin Therapeutics Inc (NASDAQ:GALT) increased during the last reporting period, rising from 5.46M to 5.52M. This put 18.41% of the company's publicly available shares short.

Short interest for Galectin Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Galectin Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 127.56K shares traded per day, it would take 43.25 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.